Deutsche Bank’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Deutsche Bank’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-571	Closed	-$30K	–	5413
2019 Q2	$30K	Buy	+571	New	+$32.8K	﹤0.01%	4701

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Deutsche Bank's GBT Position: Q4 2022 in Review

Deutsche Bank sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 265,681 shares — an estimated $18.1M sold.

Deutsche Bank first reported a position in GBT in Q3 2015 and held it in 29 quarters. The position peaked at $32.6M in Q1 2018. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Deutsche Bank reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Deutsche Bank sold 265,681 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $18.1M.
Deutsche Bank first reported a position in Global Blood Therapeutics, Inc. in Q3 2015 and held it in 29 quarters.
Deutsche Bank's Global Blood Therapeutics, Inc. position peaked at $32.6M in Q1 2018.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Deutsche Bank's 13F filing for Q4 2022, filed 13 Feb 2023.